June 25, 2025 a 03:43 pm
CVS: Fundamental Ratio Analysis - CVS Health Corporation
CVS Health Corporation remains a robust player in the healthcare sector with steady performance across various metrics. The company's strategic services in pharmacy and health insurance continue to provide it a competitive edge. Investors should note the stable growth potential along with underlying risks in the current economic climate.
Fundamental Rating
The fundamental rating for CVS Health Corporation indicates solid performance, primarily driven by its strong position in pharmacy services and healthcare benefits.
| Rating Category | Score | Visualization |
|---|---|---|
| Overall Score | 4 | |
| Discounted Cash Flow | 5 | |
| Return On Equity | 4 | |
| Return On Assets | 4 | |
| Debt To Equity | 1 | |
| Price To Earnings | 2 | |
| Price To Book | 4 |
Historical Rating
Analyzing historical ratings helps to understand the trend and performance consistency of CVS Health Corporation.
| Date | Overall Score | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-06-24 | 4 | 5 | 4 | 4 | 1 | 2 | 4 |
| 2023-06-24 | 4 | 5 | 4 | 4 | 1 | 2 | 4 |
Analyst Price Targets
Price targets reflect the valuation consensus among analysts, indicating potential future stock performance.
| High | Low | Median | Consensus |
|---|---|---|---|
| $79 | $77 | $78 | $78 |
Analyst Sentiment
Current analyst recommendations indicate a consensus leaning towards a 'Buy' rating for CVS Health Corporation.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 2 | |
| Buy | 30 | |
| Hold | 9 | |
| Sell | 0 | |
| Strong Sell | 0 |
Conclusion
CVS Health Corporation presents a strong case for investment in the healthcare industry, with positive returns on equity and assets. The fundamental ratings are reinforced by analyst sentiments, painting an optimistic picture for potential investors. The ongoing demand for healthcare and pharmacy services positions the company well for future growth. However, investors should be aware of the challenges, such as market volatility and regulatory risks, that could affect performance. The risk of high debt-to-equity presents a consideration for cautious investment.